Cargando…

PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS

OBJECTIVE: To describe the prevalence of neutralizing antibodies against poliovirus (PV1, PV2, and PV3) in blood samples of healthcare professionals aged 20 to 50 years. METHODS: Health professionals who serve children at Darcy Vargas Children’s Hospital and the Department of Pediatrics of Irmandade...

Descripción completa

Detalles Bibliográficos
Autores principales: de Moraes, José Cassio, Rujula, Maria Josefa Penon, Otsuka, Marcelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade de Pediatria de São Paulo 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870095/
https://www.ncbi.nlm.nih.gov/pubmed/33566984
http://dx.doi.org/10.1590/1984-0462/2021/39/2019354
_version_ 1783648744491712512
author de Moraes, José Cassio
Rujula, Maria Josefa Penon
Otsuka, Marcelo
author_facet de Moraes, José Cassio
Rujula, Maria Josefa Penon
Otsuka, Marcelo
author_sort de Moraes, José Cassio
collection PubMed
description OBJECTIVE: To describe the prevalence of neutralizing antibodies against poliovirus (PV1, PV2, and PV3) in blood samples of healthcare professionals aged 20 to 50 years. METHODS: Health professionals who serve children at Darcy Vargas Children’s Hospital and the Department of Pediatrics of Irmandade da Santa Casa de São Paulo. The sample size was calculated at 323 participants. The Mantel-Haenszel chi-square was used to verify differences between groups. The neutralization reaction detected human poliovirus antibodies. For susceptible individuals, vaccination with the inactivated+triple acellular polio vaccine was performed, and neutralizing antibodies were re-dosed after one week. RESULTS: 333 professionals were studied - 92.8% were immune to poliovirus 1, 86.5% to poliovirus 2, and 63.3% to poliovirus 3; 37% had titers less than 1:8 for any serotype, 5;1% had titers below 1:8 for all three. Vaccination with inactivated polio vaccine was performed for susceptible participants, and neutralizing antibodies were dosed after one week, showing increased titers for all polioviruses. CONCLUSIONS: Despite the detection of a significant percentage of individuals with low poliovirus antibody titer, the challenge with vaccination demonstrated immune response compatible with poliovirus immunity.
format Online
Article
Text
id pubmed-7870095
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade de Pediatria de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-78700952021-02-18 PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS de Moraes, José Cassio Rujula, Maria Josefa Penon Otsuka, Marcelo Rev Paul Pediatr Original Article OBJECTIVE: To describe the prevalence of neutralizing antibodies against poliovirus (PV1, PV2, and PV3) in blood samples of healthcare professionals aged 20 to 50 years. METHODS: Health professionals who serve children at Darcy Vargas Children’s Hospital and the Department of Pediatrics of Irmandade da Santa Casa de São Paulo. The sample size was calculated at 323 participants. The Mantel-Haenszel chi-square was used to verify differences between groups. The neutralization reaction detected human poliovirus antibodies. For susceptible individuals, vaccination with the inactivated+triple acellular polio vaccine was performed, and neutralizing antibodies were re-dosed after one week. RESULTS: 333 professionals were studied - 92.8% were immune to poliovirus 1, 86.5% to poliovirus 2, and 63.3% to poliovirus 3; 37% had titers less than 1:8 for any serotype, 5;1% had titers below 1:8 for all three. Vaccination with inactivated polio vaccine was performed for susceptible participants, and neutralizing antibodies were dosed after one week, showing increased titers for all polioviruses. CONCLUSIONS: Despite the detection of a significant percentage of individuals with low poliovirus antibody titer, the challenge with vaccination demonstrated immune response compatible with poliovirus immunity. Sociedade de Pediatria de São Paulo 2021-02-03 /pmc/articles/PMC7870095/ /pubmed/33566984 http://dx.doi.org/10.1590/1984-0462/2021/39/2019354 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
de Moraes, José Cassio
Rujula, Maria Josefa Penon
Otsuka, Marcelo
PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS
title PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS
title_full PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS
title_fullStr PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS
title_full_unstemmed PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS
title_short PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS
title_sort prevalence of neutralizing antibodies against poliovirus 1, 2, and 3 in healthcare professionals aged 20-50 years
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870095/
https://www.ncbi.nlm.nih.gov/pubmed/33566984
http://dx.doi.org/10.1590/1984-0462/2021/39/2019354
work_keys_str_mv AT demoraesjosecassio prevalenceofneutralizingantibodiesagainstpoliovirus12and3inhealthcareprofessionalsaged2050years
AT rujulamariajosefapenon prevalenceofneutralizingantibodiesagainstpoliovirus12and3inhealthcareprofessionalsaged2050years
AT otsukamarcelo prevalenceofneutralizingantibodiesagainstpoliovirus12and3inhealthcareprofessionalsaged2050years